Grifols considers a potential US IPO of its US biopharma unit as part of its self-sufficiency plan. Read more here. Spanish pharma Grifols, S.A. (GRFS) said that its board has decided to evaluate a po...
JAMA Network Open study finds kickback penalties dwarfed by profits: $10.25 billion in penalties versus U.S. revenue of $458.6 billion on drug sales. Pharmaceutical companies that were penalized for k...
JAMA Network Open study finds kickback penalties dwarfed by profits: $10.25 billion in penalties versus U.S. revenue of $458.6 billion on drug sales. Pharmaceutical companies that were penalized for k...
JAMA Network Open study finds kickback penalties dwarfed by profits: $10.25 billion in penalties versus U.S. revenue of $458.6 billion on drug sales. Pharmaceutical companies that were penalized for k...
The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients
More than 5,000 shelved drug candidates were discontinued for business reasons, not safety ones. A new push aims to match them with the highest need. Pfizer once shelved an experimental cancer drug. T...
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, h...
Talking Points business briefs HOUSING Mortgage rates jumped by the most in almost a year as inflation fears stoked by the war with Iran added uncertainty for the upcoming spring sales season. The ave...
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, h...
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, h...
Thermo Fisher Scientific’s pharmaceutical services business has won a number of contracts to help its customers move production from Europe or Asia to the U.S., the medical equipment maker’...
